Free. Unsubscribe any time.
Avalo Therapeutics, Inc. (AVTX)
Avalo Therapeutics, Inc. filed 19 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 38 transactions and 385,644 shares. None carries the SEC's AFF10B5ONE flag; all 19 name a plan in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2026-09-11, came 10 days after the one before it (2026-09-01) and reports 3 transactions against 3 in the filing before it.
- The sales it reports total 10,185 shares, 9,506 more than the 679 in the filing before it.
- Its 19 filings on file run from 2026-04-03 to 2026-09-11, and state 4 plan adoption dates, from 2025-11-12 to 2026-05-18.
Trades in Avalo Therapeutics, Inc. 38
- Doyle Mittie — 2026-04-01 · S · 679 shares
- Sullivan Christopher Ryan — 2026-04-01 · S · 500 shares
- Sullivan Christopher Ryan — 2026-04-01 · S · 7,479 shares
- Sullivan Christopher Ryan — 2026-04-02 · S · 6,200 shares
- Sullivan Christopher Ryan — 2026-04-02 · S · 1,780 shares
- Doyle Mittie — 2026-04-06 · S · 3,970 shares
- Sullivan Christopher Ryan — 2026-04-29 · S · 8,458 shares
- Sullivan Christopher Ryan — 2026-04-30 · S · 8,457 shares
- Doyle Mittie — 2026-05-05 · S · 1,679 shares
- Chan Mitchell — 2026-05-06 · S · 3,167 shares
- Doyle Mittie — 2026-05-06 · S · 27,538 shares
- Doyle Mittie — 2026-05-06 · S · 5,000 shares
Adoption dates in Avalo Therapeutics, Inc. 4
- 2025-11-12 — stated in 5 filings
- 2025-11-13 — stated in 11 filings
- 2025-11-19 — stated in 1 filing
- 2026-05-18 — stated in 2 filings
Results prints in Avalo Therapeutics, Inc. 0
Trades before a print in Avalo Therapeutics, Inc. 0
Interval to Avalo Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 38no later print
Adoption dates Avalo Therapeutics, Inc. states
- 2025-11-12 in 5 filings
- 2025-11-13 in 11 filings
- 2025-11-19 in 1 filing
- 2026-05-18 in 2 filings
Filing text: “10b5-1 trading plan adopted by the Reporting Person on November 12, 2025”
Sources: SEC EDGAR full-text search and the SEC submissions API.